Entity Common Stock, Shares Outstanding of Crinetics Pharmaceuticals, Inc. from 31 Oct 2018 to 13 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Oct 2018 to 13 Feb 2026.
  • Crinetics Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Feb 2026 was 104,705,330.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Crinetics Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 104,705,330 13 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 94,891,840 +2,154,213 +2.3% 28 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 94,175,994 +14,140,384 +18% 29 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 93,680,130 +14,820,620 +19% 02 May 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 92,737,627 +38,051,077 +70% 08 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 80,035,610 05 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 78,859,510 +24,833,407 +46% 06 May 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 54,686,550 +876,074 +1.6% 31 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 54,026,103 +6,241,492 +13% 05 May 2023 10-Q 09 May 2023 2023 Q1
Q3 2022 53,810,476 +6,310,590 +13% 09 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 53,752,778 +15,189,118 +39% 09 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 47,784,611 +10,191,240 +27% 25 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 47,499,886 +14,577,558 +44% 31 Oct 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 38,563,660 +5,680,078 +17% 31 Jul 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 37,593,371 +4,747,799 +14% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 32,922,328 +8,700,032 +36% 31 Oct 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 32,883,582 +8,683,610 +36% 31 Jul 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 32,845,572 +8,707,395 +36% 30 Apr 2020 10-Q 08 May 2020 2020 Q1
Q3 2019 24,222,296 +185,313 +0.77% 31 Oct 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 24,199,972 31 Jul 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 24,138,177 30 Apr 2019 10-Q 13 May 2019 2019 Q1
Q3 2018 24,036,983 31 Oct 2018 10-Q 13 Nov 2018 2018 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.